News
1d
News-Medical.Net on MSNNasal antibody spray shields mice from pollen-triggered allergies and asthmaIntranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...
Two Vacaville police officers were released from the hospital after showing signs of possible fentanyl exposure during a ...
If you look at the history of the S&P 500 ( ^GSPC -0.40%) index, dividend stocks have played a significant role in ...
The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...
It’s not every day we use Narcan on a four-legged patient—but our teams are ready for just about anything,” the department ...
2d
The Brighterside of News on MSNOxytocin nasal spray shows promise for treating alcoholism and obesityOxytocin, often called the “love hormone” for its role in social bonding and maternal behaviors, is now being investigated for something unexpected—its ability to regulate addictive behaviors and ...
MARYVILLE/GRANITE CITY/BELLEVILLE - Chestnut Health Systems will offer free virtual NARCAN training.At 10 a.m. and 2 p.m. on ...
13d
Onlymyhealth on MSNThe Hidden Dangers Of Nasal Polyps: Why A Stuffy Nose Isn't Just A Cold?Learn about nasal polyps a condition that can be mistaken for a common cold and how to identify and treat them effectively ...
A mid-stage trial of BPL‑003 nasal spray shows promising results for treatment-resistant depression, igniting biotech ...
A pharmaceutical company is closing its Wilmington manufacturing facility this year and plans to lay off 75 people who work ...
A panelist discusses how a prospective study demonstrated that twice-daily use of a nasal spray significantly improved tear ...
Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (Milestone) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results